MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to cullinan
-$219,879K
Net loss
-$219,879K
Net loss before
income taxes
-$219,879K
Interest income
$22,212K
Loss from operations
-$241,648K
Other income
(expense), net
-$443K
Total operating
expenses
$241,648K
Research and development
$187,402K
General and
administrative expense
$54,246K
Back
Back
Income Statement
source: myfinsight.com
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)